Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/134325
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells |
Autor: | Citterio, Carmen CSIC; Menacho-Márquez, Mauricio CSIC ORCID; García-Escudero, Ramón CSIC ORCID; Larive, Romain M. CSIC; Barreiro, Olga; Sánchez-Madrid, Francisco; Paramio, Jesús M.; Bustelo, Xosé R. CSIC ORCID | Fecha de publicación: | 2012 | Editor: | American Association for the Advancement of Science | Citación: | Science Signaling 5(244): ra71 (2012) | Resumen: | The guanosine triphosphatases of the Rho and Rac subfamilies regulate protumorigenic pathways and are activated by guanine nucleotide exchange factors (Rho GEFs), which could be potential targets for anticancer therapies. We report that two Rho GEFs, Vav2 and Vav3, play synergistic roles in breast cancer by sustaining tumor growth, neoangiogenesis, andmany of the steps involved in lung-specific metastasis. The involvement of Vav proteins in these processes did not correlate with Rac1 and RhoA activity or cell migration, implying the presence of additional biological programs. Microarray analyses revealed that Vav2 and Vav3 controlled a vast transcriptional program in breast cancer cells through mechanisms that were shared between the two proteins, isoform-specific or synergistic. Furthermore, the abundance of Vavregulated transcripts wasmodulated by Rac1-dependent and Rac1-independent pathways. This transcriptome encoded therapeutically targetable proteins that played nonredundant roles in primary tumorigenesis and lung-specific metastasis, such as integrin-linked kinase (Ilk), the transforming growth factor-β family ligand inhibin βA, cyclooxygenase-2, and the epithelial cell adhesionmolecule Tacstd2. It also contained gene signatures that predicted disease outcome in breast cancer patients. These results identify possible targets for treating breast cancer and lung metastases and provide a potential diagnostic tool for clinical use. | Versión del editor: | http://dx.doi.org/10.1126/scisignal.2002962 | URI: | http://hdl.handle.net/10261/134325 | DOI: | 10.1126/scisignal.2002962 | Identificadores: | doi: 10.1126/scisignal.2002962 issn: 1945-0877 e-issn: 1937-9145 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Vav2-3.pdf | 40,78 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
96
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
88
checked on 23-feb-2024
Page view(s)
245
checked on 24-abr-2024
Download(s)
673
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.